Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors–Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment
Yoshie Yoshikawa, Kozo Kuribayashi, Toshiyuki Minami and 2 more
Frontiers in Oncology · 2020
doi:10.3389/fonc.2020.554570 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
References78
- 17.
39 more references, whose wording the paper’s licence keeps private.
All 78 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.